Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013


Protein-Protein Interaction

23 Oct 2013 - 25 Oct 2013 - Paradise Point Resort & Spa, San Diego, CA



Bookmark and Share


The relatively new field of Protein-Protein Interaction (PPI) is experiencing fantastic growth in the field of drug discovery. Since promises of combinatorial chemistry and screens based on reporter systems for receptor libraries have failed, big pharma has taken a step back and is no longer investing in R&D as heavily. 

Although PPI has been around for a while as a field, it is an exciting and dynamic category of drug targets. The key concepts of PPI are to understand how proteins interact, to understand why inhibiting them is beneficial (anti-proliferative, anti-inflammatory), and how to identify molecules that block the interactions as treatment strategies. 

These concepts and much more will be covered at the inaugural Protein-Protein Interaction Conference. Below are the topics and panels for this year's event.

Sessions of the conference include:

  1. Theory & Computation
    Innovative Computational Approaches & Technologies
    Theory, Docking & Encounter Complexes
  2. Design & Evolution
    Novel Scaffolds and Inhibitors of PPI
    PPI Evolution & Design
  3. Biophysical Studies of PPIs
    Non-Specific Interactions and Protein Crowding
  4. Protein-Protein Interactions as Drug Targets
    Preclinical & Basic Research Applications
    Novel Advances is SMIPPIs Research
  5. Protein Interactions in the Membrane
    Membrane Proteins & Large Complexes
  6. Networks of Protein-Protein Interactions 
    New Methods for PPI Screening
  7. Modulation of PPIs
    Technologies & New Approaches

There will also be several interactive Panel Discussions on:

  1. Industry & Academia Collaborations
  2. Community Data Sharing - Standardization & Challenges
The conference will run parallel with 3 other information-packed conference as part of the Protein Discovery Summit:
Antibody and Protein Therapeutics
Protein Expression & Formulation
2nd Protein Kinases and Drug Design



Further information
Scientific News
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!